This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ISTA Pharmaceuticals Investor Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate The Acquisition Of ISTA Pharmaceuticals, Inc. By Bausch + Lomb

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of ISTA Pharmaceuticals, Inc. (“ISTA”) (NASDAQ: ISTA) to Bausch + Lomb for shareholders. Under the proposed transaction, ISTA shareholders will receive only $9.10 in cash for each share of ISTA stock owned, which is well below the 52-week high of $11.39 per share.

If you are an affected investor, and you want to learn more about the lawsuit or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at patrick@powerstaylor.com, or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at WBriscoe@TheBriscoeLawFirm.com. There is no cost or fee to you.

The definitive acquisition agreement involves an all cash transaction with a total equity value of approximately $500 million. The deal is expected to close in the second quarter of 2012.

The investigation centers on whether ISTA shareholders are receiving adequate compensation for their shares in the buyout, whether the transaction undervalues ISTA stock, and whether ISTA board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal. According to Yahoo! Finance, at least one analyst has stated that the true inherent value of ISTA may be as high as $12.00 per share, far higher than the current price being offered to shareholders. According to shareholder rights attorney Willie Briscoe, “Based on the lack of a significant premium to ISTA shareholders and the fact that the sale price is well below the median target price set by analysts, the firms believe that the buyout price may not be fair to ISTA shareholders. Our proposed shareholder lawsuit seeks to obtain the highest share price for all shareholders.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs